A phase I study of carboplatin, paclitaxel and vinorelbine alternating with cisplatin and topotecan in patients with advanced ovarian cancer and peritoneal cancer
Phase of Trial: Phase I
Latest Information Update: 07 Jun 2009
At a glance
- Drugs Carboplatin; Cisplatin; Paclitaxel; Topotecan; Vinorelbine
- Indications Ovarian cancer; Peritoneal cancer
- Focus Adverse reactions
- 07 Jun 2009 Planned number of patients changed from 30 to 30.
- 20 Jan 2006 New trial record.